BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29316983)

  • 1. Urogenital schistosomiasis in Cabo Delgado, northern Mozambique: baseline findings from the SCORE study.
    Phillips AE; Gazzinelli-Guimarães PH; Aurelio HO; Dhanani N; Ferro J; Nala R; Deol A; Fenwick A
    Parasit Vectors; 2018 Jan; 11(1):30. PubMed ID: 29316983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique.
    Phillips AE; Gazzinelli-Guimaraes PH; Aurelio HO; Ferro J; Nala R; Clements M; King CH; Fenwick A; Fleming FM; Dhanani N
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006061. PubMed ID: 29220347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 5-Year intervention study on elimination of urogenital schistosomiasis in Zanzibar: Parasitological results of annual cross-sectional surveys.
    Knopp S; Ame SM; Person B; Hattendorf J; Rabone M; Juma S; Muhsin J; Khamis IS; Hollenberg E; Mohammed KA; Kabole F; Ali SM; Rollinson D
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007268. PubMed ID: 31059495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urogenital schistosomiasis and associated determinant factors among senior high school students in the Dutsin-Ma and Safana Local Government Areas of Katsina State, Nigeria.
    Atalabi TE; Lawal U; Akinluyi FO
    Infect Dis Poverty; 2016 Aug; 5(1):69. PubMed ID: 27480058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schistosomiasis in school-age children in Burkina Faso after a decade of preventive chemotherapy.
    Ouedraogo H; Drabo F; Zongo D; Bagayan M; Bamba I; Pima T; Yago-Wienne F; Toubali E; Zhang Y
    Bull World Health Organ; 2016 Jan; 94(1):37-45. PubMed ID: 26769995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the impact of biannual school-based and community-wide treatment on urogenital schistosomiasis in Niger.
    Phillips AE; Tohon Z; Dhanani NA; Sofo B; Gnandou I; Sidikou B; Noma AG; Madougou B; Alto O; Sebangou H; Halilou KM; Andia R; Garba A; Fenwick A; Hamidou AA
    Parasit Vectors; 2020 Nov; 13(1):557. PubMed ID: 33203477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa.
    Kabuyaya M; Chimbari MJ; Manyangadze T; Mukaratirwa S
    Infect Dis Poverty; 2017 Apr; 6(1):83. PubMed ID: 28385154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endemic status of urogenital schistosomiasis and the efficacy of a single-dose praziquantel treatment in unmapped rural farming communities in Oyo East Local Government Area, Oyo State, Nigeria.
    Odaibo AB; Komolafe AK; Olajumoke TO; Diyan KD; Aluko DA; Alagbe OA; Ajagbe OA; Olarinloye DB
    PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012101. PubMed ID: 38620032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current epidemiological status of urogenital schistosomiasis among primary school pupils in Katsina State, Nigeria: An imperative for a scale up of water and sanitation initiative and mass administration of medicines with Praziquantel.
    Atalabi TE; Adoh SD; Eze KM
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006636. PubMed ID: 29979684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and intensity of genito-urinary schistosomiasis and associated risk factors among junior high school students in two local government areas around Zobe Dam in Katsina State, Nigeria.
    Atalabi TE; Lawal U; Ipinlaye SJ
    Parasit Vectors; 2016 Jul; 9(1):388. PubMed ID: 27388007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significantly reduced intensity of infection but persistent prevalence of schistosomiasis in a highly endemic region in Mali after repeated treatment.
    Landouré A; Dembélé R; Goita S; Kané M; Tuinsma M; Sacko M; Toubali E; French MD; Keita AD; Fenwick A; Traoré MS; Zhang Y
    PLoS Negl Trop Dis; 2012; 6(7):e1774. PubMed ID: 22860153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of persistent hotspots of Schistosoma mansoni in western Côte d'Ivoire.
    Assaré RK; N'Tamon RN; Bellai LG; Koffi JA; Mathieu TI; Ouattara M; Hürlimann E; Coulibaly JT; Diabaté S; N'Goran EK; Utzinger J
    Parasit Vectors; 2020 Jul; 13(1):337. PubMed ID: 32616074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urogenital schistosomiasis and risk factors of infection in mothers and preschool children in an endemic district in Zimbabwe.
    Mutsaka-Makuvaza MJ; Matsena-Zingoni Z; Katsidzira A; Tshuma C; Chin'ombe N; Zhou XN; Webster B; Midzi N
    Parasit Vectors; 2019 Sep; 12(1):427. PubMed ID: 31477172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries.
    Shen Y; King CH; Binder S; Zhang F; Whalen CC; Evan Secor W; Montgomery SP; Mwinzi PNM; Olsen A; Magnussen P; Kinung'hi S; Phillips AE; Nalá R; Ferro J; Aurelio HO; Fleming F; Garba A; Hamidou A; Fenwick A; Campbell CH; Colley DG
    BMC Infect Dis; 2017 Sep; 17(1):652. PubMed ID: 28962552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of integrated interventions layered on mass drug administration for urogenital schistosomiasis elimination: a cluster-randomised trial.
    Knopp S; Person B; Ame SM; Ali SM; Hattendorf J; Juma S; Muhsin J; Khamis IS; Mohammed KA; Utzinger J; Hollenberg E; Kabole F; Rollinson D
    Lancet Glob Health; 2019 Aug; 7(8):e1118-e1129. PubMed ID: 31255591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of praziquantel mass drug administration campaign on prevalence and intensity of Schistosoma haemamtobium among school children in Bahi district, Tanzania.
    Chaula SA; Tarimo DS
    Tanzan J Health Res; 2014 Jan; 16(1):1-8. PubMed ID: 26867266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human schistosomiasis in Benin: Countrywide evidence of Schistosoma haematobium predominance.
    Onzo-Aboki A; Ibikounlé M; Boko PM; Savassi BS; Doritchamou J; Siko EJ; Daré A; Batcho W; Massougbodji A; Tougoue JJ; Kaboré A
    Acta Trop; 2019 Mar; 191():185-197. PubMed ID: 30633895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors of schistosomiasis among primary school children in four selected regions of The Gambia.
    Joof E; Sanyang AM; Camara Y; Sey AP; Baldeh I; Jah SL; Ceesay SJ; Sambou SM; Sanyang S; Wade CM; Sanneh B
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009380. PubMed ID: 33974623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Single Dose Praziquantel Treatment on Schistosoma haematobium Infection among School Children in an Endemic Nigerian Community.
    Adewale B; Mafe MA; Sulyman MA; Idowu ET; Ajayi MB; Akande DO; Mckerrow JH; Balogun EO
    Korean J Parasitol; 2018 Dec; 56(6):577-581. PubMed ID: 30630278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.